Quantifying lower limb muscle weakness in Osteogenesis Imperfecta Type IV

6702
New study finds lower limb muscle deficits despite normal upper-limb muscle force in children and adolescents with OI type IV; fracture history found to be significant negative predictor.

Osteogenesis Imperfecta (OI) is a heritable disorder characterized by increased bone fragility.

In OI Type IV muscle weakness has important functional consequences. Children and adolescents with OI type IV often have restricted mobility despite multidisciplinary treatment with bisphosphonates, intramedullary rodding surgery and rehabilitation.

To date, muscle function, and in particular that of the lower extremity, in OI type IV has not been investigated systematically. A new study in the journal Calcified Tissue International has now assessed upper and lower extremity muscle function in 27 children and adolescents aged 7-21 years with OI type IV, compared with age-and sex-matched controls. The researchers found that the patients, all with a clinical diagnosis of OI type IV and known mutations in the COLIA1 and COLIA2 genes, had:

  • approximately 30% lower-limb peak force and 50% peak power deficits compared to healthy age- and sex-matched controls. 
  • at the lower limb level, a 50% lower peak power than age- and sex- matched patients with OI type 1 (the type of OI with the mildest form of bone fragility).
  • normal upper-limb muscle force, but a muscle function deficit at the lower-limb level.

Among the potential determinants of lower-limb muscle function in OI type IV, only fracture history emerged as a significant negative predictor. The number of fractures is likely to explain periods of inactivity which contributes to lower muscle function. Muscle function may also be impaired by a direct effect of collagen type 1 mutations on tendons, ligaments and intramuscular connective tissue, although more studies are needed to clarify this aspect.

The results suggest that lower limb weakness may contribute to limitations in mobility in people with OI Type IV despite multidisciplinary treatment.

Reference
Veilleux, LN., Darsaklis, V.B., Montpetit, K. et al. Muscle Function in Osteogenesis Imperfecta Type IV Calcif Tissue Int (2017). doi:10.1007/s00223-017-0287-y
https://link.springer.com/article/10.1007/s00223-017-0287-y

About Calcified Tissue International & Musculoskeletal Research
Calcified Tissue International & Musculoskeletal Research is a peer-reviewed journal which publishes original preclinical, translational and clinical research, and reviews concerning the structure and function of bone, and other musculoskeletal tissues in living organisms, as well as clinical studies of musculoskeletal disease. It includes studies of cell biology, molecular biology, intracellular signalling, and physiology, as well as research into the hormones, cytokines and other mediators that influence the musculoskeletal system. The journal also publishes clinical studies of relevance to bone disease, mineral metabolism, muscle function, and musculoskeletal interactions.
Editors in Chief: Stuart Ralston and René Rizzoli; Musculoskeletal Research Section Editor: Roger Fielding.